🔎 Trials Near Me

Akèy › Obèsite › Florid › Miami

Etid klinik pou Obèsite nan Miami, FL

27 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Miami (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Ap rekriteFaz 1
  • Clinical Pharmacology of Miami, Miami
Laj 18 a 65 · Tout sèks · Mizajou Sep 28, 2026 · NCT07399678

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Ap rekriteFaz 3
  • PharmaDev Clinical Research Institute LLC, Miami
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07668414

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Ap rekriteFaz 3
  • Research Associates of South Florida - Miami - Southwest 8th Street, Miami
  • Gastro Health Research - Miami, Miami
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Ap rekriteFaz 3
  • Research Associates of South Florida - Miami - Southwest 8th Street, Miami
  • Gastro Health Research - Miami, Miami
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937086

A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity

Ap rekriteFaz 1
  • Clinical Pharmacology of Miami, Miami
Laj 18 a 70 · Tout sèks · Mizajou Sep 23, 2026 · NCT07803744

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Ap rekriteFaz 3
  • Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
  • New Horizon Research Center, Miami
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Ap rekriteFaz 3
  • New Horizon Research Center, Miami
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Ap rekriteFaz 3
  • Flourish Research - Miami, LLC, Miami
  • PharmaDev Clinical Research Institute, LLC, Miami
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Finlay Medical Research, Miami
  • Suncoast Research Group LLC, Miami
  • New Horizon Research Center, Miami
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • BioMed Research & Medical Center, Miami
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • New Horizon Research Center, Miami
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589608

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Ap rekriteFaz 3Volontè an sante akeyi
  • ACCOMPLISH-2 Research Site, Miami
Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • New Horizon Research Center, Miami
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Ap rekriteFaz 3
  • Kailera Clinical Site, Miami
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3
  • Optimus U Corporation, Miami
  • Research Institute of South Florida, Miami
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Ap rekriteFaz 3
  • Optimus U Corporation, Miami
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Ap rekriteFaz 3
  • New Horizon Research Center, Miami
  • Research Institute of South Florida, Miami
Laj 18 a 99 · Tout sèks · Mizajou Aug 27, 2026 · NCT07575399

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • Total Research Group LLC, Miami
  • Infinite Clinical Research, Miami
  • Future Life Clinical Trials, Miami
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Ap rekriteFaz 3
  • ACCOMPLISH-1 Research Site, Miami
Laj 18 a 79 · Tout sèks · Mizajou Aug 10, 2026 · NCT07654361

First in Human Study in Subjects With Obesity, But Otherwise Healthy

Ap rekriteFaz 1
  • Clinical Pharmacology of Miami, LLC, Miami
Laj 18 a 65 · Tout sèks · Mizajou Apr 9, 2026 · NCT06252220

Efficacy Trial of Healthy Together ("Juntos")

Ap rekriteVolontè an sante akeyi
  • University of Miami, Miami
Laj 12 a 15 · Tout sèks · Mizajou Mar 23, 2026 · NCT06489262

With Love, Grandma ("Con Cariño, Abuelita") Pilot Study

Ap rekrite
  • University of Miami, Miami
Laj 21 ak plis · Fanm · Mizajou Feb 25, 2026 · NCT05721976

Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Laj 12 a 17 · Tout sèks · Mizajou Sep 10, 2025 · NCT06596265

Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Laj 6 a 14 · Tout sèks · Mizajou Sep 4, 2025 · NCT06595251

Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Laj 50 a 95 · Tout sèks · Mizajou Sep 4, 2025 · NCT06604650

RESET System Pivotal Trial (Rev F)

Ap rekrite
  • University of Miami Hospital, Miami
Laj 22 a 65 · Tout sèks · Mizajou Jul 18, 2024 · NCT04101669

Etid Obèsite nan lòt vil

Lòt etid nan Miami

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.